Error loading player: No playable sources found
Session V: Multispecifics and ADCs Characterization
Date
September 12, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Session Chairs: Chris Chumsae, Bristol-Myers Squibb Company and Frances Namuswe, CDER, FDA
Session Speakers:
Glyco-Analysis of a Glycoengineered VHH-Radioligand Therapy Designed for Improved Biodistribution
David Bush, Novartis
Characterization of ADCs in Serum and Formulation Buffer
Tun Liu, Johnson & Johnson
Development of Novel Chromatographic and Mass Spectrometric Techniques for Characterizations of BsAbs and ADCs
Fengfei Ma, Merck & Co., Inc.
Session Chairs
Speakers
Related Products
Session VIII: MAM for Product & Process Characterization & Quality Control
Session Chairs: Ingo Lindner,_ Roche Diagnostics GmbH_ and Da Ren, _BioTherapeutics Solutions_
Diverse Voices: Breakfast Session
Diversity is not a _color. _It is who is represented in the workplace, research, and society. Examples include gender diversity, age diversity, ethnic diversity, physical ability and neurodiversity…
Session III: Joint MS/HOS Plenary Session: Mass Spec Technologies in HOS / Comprehensive Toolboxes for Complex Problems
Session Chair: Frances Namuswe, _CDER, FDA_
Session I: Molecular Design, Developability and Biotransformation
Session Chairs: Jason Rouse,_ Pfizer, Inc…
